Anti-immunoglobulin E therapy on chronic prurigo and cholinergic urticaria

JRCT ID: jRCTs031180092

Registered date:22/01/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Chronic prurigo and cholinergic urticaria
• Date of first enrollment: 20/03/2018
• Target sample size: 10
• Study type: Interventional
• Intervention(s): treatment

Outcome(s)

• Primary Outcome: skin symptom
• Secondary Outcome: itch, QOL, Blood examination

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

patients who are resistant to the treatments such as topical administration of steroid and orally administration of anti-histamine drugs
patients at age 20 or over
out patients

Exclude criteria

patients orally administrated immune suppressants or high-dose steroid within three months.
patients suffering from severe visceral diseases, autoimmune diseases, blood dosorders, and mental disorders
patients who is pregnant or breast-feed
patients judged inadequate to this study

Related Information

• Primary Sponsor: Yokozeki Hiroo
• Source(s) of Monetary Support: MEXT KAKENHI